Martin & Brown Bio-Sciences Private Limited

Martin & Brown Bio-Sciences Private Limited - pharma in Nalagarh, Himachal Pradesh, India. Directors, charges & compliance details.
CIN U21009HP2023PTC010046 Incorporated 28 April 2023 ROC Himachal Pradesh HQ Nalagarh, Himachal Pradesh, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹88.52 Cr
▲ 75% YoY
Net profit · FY 2025
₹1.51 Cr
Net margin 1.7%
EBITDA · FY 2025
₹4.66 Cr
EBITDA margin 5.3%
Authorised capital
₹6.4 Cr
Registered with MCA
Paid-up capital
₹5.53 Cr
Issued & subscribed
Open charges
₹18.04 Cr
Secured borrowings
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings

About Martin & Brown Bio-Sciences Private Limited

Data last updated:

Martin & Brown Bio-Sciences Private Limited is a private limited company based in Nalagarh, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 April 2023.

The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U21009HP2023PTC010046.

The company has an authorised share capital of ₹6.4 Cr and a paid-up capital of ₹5.53 Cr. It is led by directors Puneet Maini and Vineet Maini.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khasra No 918/419 Malku Majra, Nalagarh, Himachal Pradesh, India – 173205.

As per the financials filed for FY 2025, the company reported a revenue of ₹88.52 Cr, a growth of 75% compared to the previous year. For the same year it recorded a net profit of ₹1.51 Cr (net margin 1.7%) and EBITDA of ₹4.66 Cr (EBITDA margin 5.3%).

As per MCA filings, the company has open charges of ₹18.04 Cr on record. Court records list 20 cases involving the company, including 12 filed by the company and 8 filed against it; 12 cases are pending.

Martin & Brown Bio-Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0018951).

Company details

CIN U21009HP2023PTC010046
Registration Number 010046
Incorporation Date 28 April 2023
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Medium
Udyam Registration UDYAM-HP-11-0018951

Recognitions & Rankings of Martin & Brown Bio-Sciences

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-HP-11-0018951

Contact details

Martin & Brown Bio-Sciences Private Limited's registered office is in Nalagarh, Himachal Pradesh.

  • Registered Address
    Khasra No 918/419 Malku Majra, Nalagarh, Himachal Pradesh, India – 173205
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Martin & Brown Bio-Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Martin & Brown Bio-Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Martin & Brown Bio-Sciences Private Limited, buy the company report.

Financials of Martin & Brown Bio-Sciences Private Limited

FY 2025 filings available

Martin & Brown Bio-Sciences Private Limited reported revenue of ₹88.52 Cr (up 75% YoY) for FY 2025.

Revenue · FY 2025
₹88.52 Cr ▲ 75%
Net profit · FY 2025
₹1.51 Cr margin 1.7%
EBITDA · FY 2025
₹4.66 Cr margin 5.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 75%
EBITDA CAGR growth
1 year
▲ 29%

Revenue rose 75% in the latest year. EBITDA rose 29% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.66 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.51 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24
Profitability
EBITDA Margin5.3%
Net Profit Margin1.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Martin & Brown Bio-Sciences Private Limited, buy the company report.

Board of directors of Martin & Brown Bio-Sciences Private Limited

Martin & Brown Bio-Sciences has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Puneet MainiDirector28 Apr 20233 Years 6 MonthsCurrent
Vineet MainiDirector28 Apr 20233 Years 6 MonthsCurrent

Peer comparison

Martin & Brown Bio-Sciences Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Medilux Laboratories Pvt Ltd₹89.42 Cr (FY 2018)-2.0%Indore, Madhya Pradesh, India
Evertogen Life Sciences Limited₹89.28 Cr (FY 2024)51.0%Hyderabad, Telangana, India
U S Pharma (India) Private Limited₹89.26 Cr (FY 2025)421.0%Mumbai, Maharashtra, India
Gnosis Pharmaceuticals Private Limited₹88.76 Cr (FY 2024)18.0%New Delhi, Delhi, India
Martin & Brown Bio-Sciences Private Limitedthis company₹88.52 Cr (FY 2025)₹1.51 Cr1.7%75.0%Nalagarh, Himachal Pradesh, India
Ravian Life Science Private Limited₹88.41 Cr (FY 2025)2.0%Haridwar, Uttarakhand, India
SRS Pharmaceuticals Private Limited₹88.26 Cr (FY 2025)-10.0%Mumbai, Maharashtra, India
Appasamy Ocular Devices Private Limited₹87.93 Cr (FY 2022)60.0%Chennai, Tamil Nadu, India
BDH Industries Limited₹87.41 Cr (FY 2024)16.0%Mumbai, Maharashtra, India

To see the full peer comparison of Martin & Brown Bio-Sciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹18.04 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹18.04 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
09 Feb 2024100888531State Bank of India₹18.04 CrOpen

To see the full charge records of Martin & Brown Bio-Sciences Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Martin & Brown Bio-Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Martin & Brown Bio-Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Martin & Brown Bio-Sciences Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Puneet Maini was appointed as Director on 28 Apr 2023.

AGM
Martin & Brown Bio-Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with State Bank Of India of Rs. 18.04 Cr registered on 09 Feb 2024 with Charge ID 100888531 was modified on 09 Sep 2025.
Filing
Martin & Brown Bio-Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh.
Charges
A charge with State Bank Of India amounted to Rs. 18.04 Cr with Charge ID 100888531 was registered on 09 Feb 2024.
Appointed
Puneet Maini was appointed as Director.
Appointed
Vineet Maini was appointed as Director.
Incorporation
28 Apr 2023
Martin & Brown Bio-Sciences Private Limited was registered on 28 Apr 2023 with Roc Himachal Pradesh & aged 3 years 6 months as per MCA records.

Frequently asked questions

Martin & Brown Bio-Sciences is an active private limited company based in Nalagarh, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 April 2023 (3+ years old) and is registered under CIN U21009HP2023PTC010046.

Martin & Brown Bio-Sciences has 2 current directors:

The latest financial statements of Martin & Brown Bio-Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.

The CIN (Corporate Identification Number) of Martin & Brown Bio-Sciences is U21009HP2023PTC010046. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Martin & Brown Bio-Sciences has 20 court cases on record: 12 filed by the company and 8 filed against it. 12 are pending. Most are in the high courts.

Martin & Brown Bio-Sciences was incorporated on 28 April 2023, making it 3+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.

The peers of Martin & Brown Bio-Sciences by revenue are Medilux Laboratories Pvt Ltd, Evertogen Life Sciences Limited, U S Pharma (India) Private Limited, Gnosis Pharmaceuticals Private Limited, Ravian Life Science Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Puneet Maini was appointed as Director on 28 Apr 2023. Vineet Maini was appointed as Director on 28 Apr 2023.

Yes, Martin & Brown Bio-Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-11-0018951).

The registered office of Martin & Brown Bio-Sciences is at Khasra No 918419 Malku Majra, Nalagarh, Himachal Pradesh, India – 173205.

Martin & Brown Bio-Sciences operates in the pharma industry, in the drug formulation and development segment.